Citation Format: Ondrej Bouska, Vladimira Koudelakova, Zuzana Horakova, Marian Hajduch. HPV-related oropharyngeal cancer: Circulating and salivary DNA-based biomarkers for early diagnosis and ...

The incidence of Human Papillomavirus (HPV)–associated ... oropharyngeal cancers. The study's objective was to understand the molecular mechanisms by which hybrid ecDNA drives oropharyngeal ...

With a 3% discount rate, the lifetime cost of oropharyngeal cancer related to HPV for the target population under the no vaccination scenario is 7.72 hundred million yuan. Compared to no vaccination, ...

These assays are intended to support research of oropharyngeal cancer (OPC) linked to the human papillomavirus (HPV).The HPV virus can infect the mouth and throat and cause cancers of the oropharynx, ...

There are over 100 types of human papillomavirus (HPV), and some can lead to different types of cancer, including cancer that affects the nose and throat. These are known as HPV-associated ...

Oropharyngeal cancers associated ... of the Gleiberman Head and Neck Cancer Center at UC San Diego Moores Cancer Center. Califano’s lab is investigating which drugs work best to target ecDNA in ...

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal cancers ... HPV DNA hybridizes with human DNA genes in oropharyngeal cancer cells, forming extrachromosomal circular ...

Cancer Currents on his study using transoral robotic surgery (TORS) to treat HPV-positive oropharyngeal cancer. This approach offers a less invasive alternative to open surgery without disfigurement.